Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
Children's Hospital Medical Center, Cincinnati · NCT07477197
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 16+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 5000
- US sites recruiting
- 1
- Study start
- July 1, 2021
- Record last updated
- March 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of patient experience and functional status; associations between clinical characteristics and various biomarkers; and predictors of clinical outcomes.
Conditions: Adult Congenital Heart Disease; Pulmonary Hypertension; Connective Tissue Disease; Other Cardiovascular Conditions
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Any person ≥ 16 years-old suspected of having or diagnosed with congenital heart disease (CHD), other cardiovascular disease (CVD), pulmonary hypertension, connective tissue disease, or genetic syndrome/diagnosis.
- Additionally, a cohort (Control group A) of control subjects will be enrolled, again ≥16 years-old, self-reported non-smokers without a known history of diabetes mellitus, myocardial infarction, stroke, heart failure, or chronic kidney disease. These controls will be either:
- A family member or other person accompanying a patient to a clinical encounter; or,
- A volunteer recruited via an advertisement; or,
- Another person who volunteers to enroll in HIBR-ACHD.
- A cohort (Control group B) of comparison subjects who do not have CHD, but have a diagnosis of heart failure or pulmonary hypertension.
Exclusion Criteria
- Unable to provide informed consent/assent personally or via a legal guardian.
- Considered unsafe to collect the biospecimen determined by either a clinical provider or an HIBR-ACHD investigator.
- Overnight hospitalization for non-obstetric reason with discharge in the prior 30 days.
Recruiting US locations
Children's Hospital Medical Center, Cincinnati
Cincinnati, OH 45229
Study contacts (from the official record)
- Sasha Opotowsky, MD · 513-803-2243 · sasha.opotowsky@cchmc.org
- Lindsay Fist · lindsay.fist@cchmc.org
Similar studies in Ohio
All heart & blood pressure studies in Ohio →- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Cincinnati, OH + 30 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Cleveland, OH + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- Lima, OH + 27 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Boston Scientific Corporation
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 18+